Clinical Trial

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Study acronym: HIP ATTACK-2
Recruiting
View on ClinicalTrials.gov →
Summary
The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.
Protocol Amendment History 40 amendments
This ClinicalTrials.gov record has been amended 40 times since 2021-02-03; most recent amendment 2025-09-25.
Status change: Not Yet Recruiting → Recruiting 2021-11-30
Trial Details
NCT Number NCT04743765
Lead Sponsor Population Health Research Institute
Collaborators: Canadian Institutes of Health Research (CIHR), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions Hip Fractures, Myocardial Injury
Enrollment 1,100 participants
Start Date 2021-11-22
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-01